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Mural cells (pericytes and vascular smooth muscle
cells) provide trophic and structural support to blood
vessels. Vascular smooth muscle cells alternate
betweenasynthetic/proliferative state andadifferen-
tiated/contractile state, but the dynamic states of
pericytes are poorly understood. To explore the
cues that regulate mural cell differentiation and
homeostasis, we have generated conditional knockin
mice with activating mutations at the PDGFRb locus.
We show that increased PDGFRb signaling drives
cell proliferation and downregulates differentiation
genes in aortic vascular smooth muscle. Increased
PDGFRb signaling also induces a battery of immune
response genes in pericytes and mesenchymal cells
and inhibits differentiation of white adipocytes. Mural
cells are emerging as multipotent progenitors of
pathophysiological importance, and we identify
PDGFRb signaling as an important in vivo regulator
of their progenitor potential.
INTRODUCTION
Pericytes and vascular smooth muscle cells (VSMCs) are collec-
tively called mural cells. They are a heterogeneous class of cells,
derived from mesoderm or neural crest, which supports and
interacts with endothelial cells in the blood vessel wall. An impor-
tant distinction between pericytes and VSMCs is anatomical:
pericytes are embedded within the basement membranes of
capillaries, venules, and arterioles, whereas VSMCs are found
outside the basement membrane of larger vessels. A second
distinction is functional, where VSMCs have well-defined roles
in providing strength, resilience, and contraction to large vessels
and in repairing vascular injury. In contrast, the roles of pericytes
are poorly understood andmay include structural support for the
microvasculature, signaling to the endothelium to control cell
growth or quiescence, regulation of blood-brain barrier (BBB)
homeostasis, and potentially some immune functions. Quies-
cent VSMCs function through a smooth muscle contractile
apparatus, but they are not terminally differentiated cells; in
response to environmental cues (e.g., vascular injury, inflamma-
tion), they have the potential to downregulate their contractile
apparatus genes and reenter the cell cycle. Pericytes mayDevelpossess even greater phenotypic plasticity. They are increas-
ingly viewed as multipotent progenitor cells or mesenchymal
stem cells (MSCs) with capacity to differentiate into adipocytes,
osteoblasts, chondrocytes, and other cell types (Crisan et al.,
2008). Pericytes and MSCs may also regulate immune system
homeostasis (da Silva Meirelles et al., 2008). These properties
make them potentially useful as a source of adult stem cells for
regenerative therapies. Nevertheless, how pericyte or mesen-
chymal progenitor differentiation is regulated in a physiological
context remains unclear. It is important to understand regulatory
cues because this could offer new avenues for regenerative
medicine and might provide insight on disease processes.
Several key signaling pathways coordinate mural cell/endo-
thelial cell interactions during development, including TGF-b,
angiopoietins, sphingosine-1-phosphate, Notch, and platelet-
derived growth factor B (PDGF-B) (Armulik et al., 2005). Sprout-
ing endothelial tubes secrete PDGF-B, which signals through
the PDGF receptor b (PDGFRb) expressed in mural cell progen-
itors. This directs the recruitment and expansion of mural cell
progenitors at the site of angiogenesis, until PDGFRb is downre-
gulated as the vasculature matures. Mice lacking PDGFRb or
PDGF-B die around birth with reduced numbers of VSMCs and
organ-specific loss of pericytes, including a 95% reduction in
pericytes of the central nervous system (CNS) (Hellstro¨m et al.,
1999; Leve´en et al., 1994; Lindahl et al., 1997; Soriano, 1994).
Tissue-specific knockout of PDGF-B demonstrates that the
endothelium is the critical source of ligand for recruiting and
expanding PDGFRb-expressing mural cell progenitors (Bjarne-
ga˚rd et al., 2004). Although mice without PDGFRb signaling
develop some VSMCs, analysis of chimeric embryos with
competitive mixtures of wild-type and PDGFRb-deficient cells
has demonstrated a quantitative dependence on PDGFRb for
mural cell development (Crosby et al., 1998; Lindahl et al.,
1998; Tallquist et al., 2000).
PDGFRs are receptor tyrosine kinases with an extracellular
ligand-binding domain and a cytoplasmic enzymatic domain.
The signaling activity of PDGFRs is tightly regulated by an auto-
inhibitory allosteric conformation, and requires ligand-induced
receptor dimerization at the cell surface to alleviate autoinhibi-
tion and achieve physiological activity. Once activated, tyrosine
phosphorylation of the receptor activates a number of down-
stream signaling pathways, including Ras/MAP kinases, PI3
kinase/AKT, PLC/PKC, and Stats (Heldin and Westermark,
1999). These signaling pathways together have additive effects
on development, and the summation of pathway activity down-
stream of PDGFRb determines the degree of expansion of mural
cell progenitors (Tallquist et al., 2003). Point mutations inopmental Cell 20, 815–826, June 14, 2011 ª2011 Elsevier Inc. 815
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allow constitutive signaling in the absence of ligand (Chiara
et al., 2004; Irusta and DiMaio, 1998; Magnusson et al., 2007).
In humans, activating mutations in PDGFRa can cause gastroin-
testinal stromal tumors (Heinrich et al., 2003). Activating muta-
tions in the mouse PDGFRa lead to connective tissue hyper-
plasia in embryos and widespread organ fibrosis in adult mice
(Olson and Soriano, 2009). In contrast, the developmental and
disease consequences of increased PDGFRb signaling are still
an open question. Activating mutations in PDGFRb might alter
the developmental potential of mural cells.
PDGF ligands are expressed in many cell types in the cardio-
vascular system including endothelial cells, monocytes/macro-
phages, lymphocytes, and platelets, and aberrant PDGFRb
signaling has been implicated in cardiovascular disease (Andrae
et al., 2008; Raines, 2004). With this physiological context as a
basis for investigating the consequences of increased PDGFRb
signaling, we created two conditional knockin alleles expressing
mutant PDGFRb from the endogenous PDGFRb promoter that
are able to be conditionally activated in a tissue-specific manner.
We report that PDGFRb activation opposes the differentiation of
aortic VSMCs and brain pericytes. By microarray profiling we
define the PDGFRb-induced pericyte phenotype as involved in
immune responses, highlighting an inherent potential of micro-
vascular pericytes to mediate inflammatory and immune
signaling. We find that PDGFRb signaling in pericytes or mesen-
chymal progenitor cells inhibits the differentiation of white adipo-
cytes, providing insight into the regulation of mesenchymal
progenitor differentiation in a physiological context. The finding
that PDGF signaling can induce an immune response in peri-
cytes and influence adipocyte differentiation may promote new
approaches for understanding obesity.
RESULTS
Derivation of Knockin Mice
To explore the role of PDGFRb signaling, we generated three
lines of knockin mice expressing full-length PDGFRb cDNAs
from the endogenous PDGFRb promoter. Two lines expressed
cDNAs harboring different activating mutations, and a third line
expressed wild-type PDGFRb cDNA as a control. The first muta-
tion (V536A), designated bJ, has been characterized in the Ba/F3
cell line as a mutation conferring constitutive activation (Irusta
and DiMaio, 1998). It disrupts a highly conserved juxtamem-
brane region in type III RTKs that contacts the kinase domain
and is important for full autoinhibition (Hubbard, 2004). The
second mutation (D849V), designated bK, has been character-
ized in embryoid bodies as conferring constitutive activation
on PDGFRb (Magnusson et al., 2007). It is located in the kinase
domain and is thought to interfere with the inactive conformation
of the ATP-binding pocket. Our targeting approach allowed
conditional cDNA expression by inserting a lox-stop-lox
cassette and a splice acceptor in place of the endogenous
exon 2 (see Figure S1A available online). In the absence of Cre
recombination, knockin mice are heterozygous for PDGFRb
and are phenotypically normal (Soriano, 1994). We identified
correctly targeted ES cell clones by Southern blot (Figure S1B),
and these clones were used to derive germline chimeras for
the bWt, bJ, and bK strains.816 Developmental Cell 20, 815–826, June 14, 2011 ª2011 Elsevier IPDGFRb+/(S)Wt,PDGFRb+/(S)J, andPDGFRb+/(S)Kheterozygous
mice that carried the inactivating stop-lox-stop cassette, desig-
nated (S), were crossed to epiblast-specific Cre lines (Meox2Cre
(Tallquist and Soriano, 2000) or Sox2Cre (Hayashi et al., 2002)
to obtain mice with activated alleles in all tissues of the
embryo proper. Crosses between epiblast-specific Cre lines
and control PDGFRb+/(S)Wt parents yielded the expected ratio
ofPDGFRb+/Wt offspring that were all viable and fertile, indicating
that knockin expression of a wild-type cDNA at physiological
levels does not produce a distinguishable phenotype. In further
experiments, PDGFRb+/+ mice were used as matched controls
for their mutant littermates. Crosses between epiblast-specific
Cre and PDGFRb+/(S)J (or PDGFRb+/(S)K) parents yielded mutant
pups at the expected frequency before postnatal day 7 (P7)
(bJ = 25/94, bK = 29/105). Mutant and control pupswere indistin-
guishable from P0 until P6, but mutants were growth deficient
during the second week and usually died by P14 (Figure 1A).
We confirmed complete excision of the lox-stop-lox cassette
by quantitative real-time PCR (qRT-PCR) on tissue samples
from Sox2Cre;PDGFRb+/K pups. To test the possibility that
increased PDGFRb signaling has additional consequences in
the development of extra-embryonic organs, we used male
germline-specific PrmCre (O’Gorman et al., 1997) to generate
PDGFRb+/K mice with increased PDGFRb signaling in all embry-
onic and extra-embryonic tissues. This produced a postnatal
phenotype that was indistinguishable from epiblast-specific
Cre. From this survival data we conclude that increased PDGFRb
signaling by D849V (bK) or V536A (bJ) allows normal embryonic
development but produces postnatal phenotypes that we
describe in detail below. In all subsequent studies we have not
observed any consistent phenotypic difference between
PDGFRb+/J and PDGFRb+/K mice or cell lines, and therefore, all
presented data are representative of either allele.
To examine the basal and ligand-inducible activity of mutant
receptors, we cultured mouse embryonic fibroblasts (MEFs)
derived from control and mutant embryos. After 48 hr of serum
starvation, PDGFRb+/J and PDGFRb+/K cells retained elevated
phosphorylation of PDGFRb compared to wild-type cells (Fig-
ure 1B). PDGFRb from mutant cells was phosphorylated to
higher levels after a pulse of PDGF-BB, similar to wild-type cells,
indicating that PDGFRb+/J and PDGFRb+/K cells retain respon-
siveness to their cognate ligands. We also observed high
basal phosphorylation of PLCg1 in PDGFRb+/J and PDGFRb+/K
cells, but p42/44 and Akt were significantly phosphorylated
only with the addition of PDGF-BB (Figure 1C). Therefore, similar
to the previously reported activation of PLCg1 in PDGFRa+/J and
PDGFRa+/K MEFs (Olson and Soriano, 2009), PDGFRbJ and
PDGFRbK signaling has a specific effect on basal PLCg1
phosphorylation.
Changes in AorticWall Architecture and SmoothMuscle
Cell Phenotype with Increased PDGFRb Signaling
In search of developmental defects that might contribute to
the lethal phenotype of Sox2Cre;PDGFRb+/J and Sox2Cre;
PDGFRb+/K pups, we observed thickening of the media in the
ascending aorta during the second week (data not shown). To
isolate this phenotype from consequences of PDGFRb activation
in other tissues, we generatedmutantmicewith Sm22Cre, which
is active in VSMCs of the aorta and adjacent mesenchymalnc.
Figure 1. Constitutive and Inducible Signaling by
PDGFRb Mutant cDNA Knockins
(A) Littermates at P14.
(B) Western blot analysis of protein expression and
phosphorylation in PDGFRb+/w (Wt), PDGFRb+/J (bJ), and
PDGFRb+/K (bK) MEFs. Cells were serum starved, then
harvested directly () or stimulated with 10 ng/ml PDGF-
BB (+) for 10 min. Protein lysates were subjected to
immunoprecipitation (IP) with PDGFRb antibody and were
blotted for phosphotyrosine. On separate membranes,
equal amounts of total protein were blotted for PDGFRb.
(C) Western blot analysis of signaling protein expression
and phosphorylation in PDGFRb+/w (Wt), PDGFRb+/J (bJ),
and PDGFRb+/K (bK) MEFs. Cells were serum starved,
then harvested directly () or stimulated with 10 ng/ml
PDGF-BB (+).
See also Figure S1.
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myocytes (data not shown). The excision efficiency of the lox-
stop-lox cassette in Sm22Cre;PDGFRb+/K aortas was 71%
complete (by qRT-PCR). Activation of mutant PDGFRb in
VSMCs recapitulated the aorta phenotype seen with Sox2Cre
mice, but otherwise the mutants were viable and fertile. Aortas
from Sm22Cre;PDGFRb+/K neonates were initially histologically
normal (Figures 2C and 2D), but with age the media thickened,
leading eventually to a 2-fold dilation of the vessel (Figures 2E
and 2F). These alterations began in the ascending aorta
during the second week and progressed through the arch and
descending aorta to affect the entire thoracic and abdominal
aorta by 4 weeks. Aortic dilation appears to reach homeostasis
at this time without additional consequences because we have
never observed aortic rupture in Sm22Cre-derived mutants up
to 1 year of age (n = 10). Apoptotic cells (cleaved caspase-3+)
were not detected in aortic sections from 6-month-old
Sm22Cre;PDGFRb+/K mice (data not shown; embryonic trigem-
inal ganglion served as a positive control), suggesting that organ
homeostasis is achieved by aortic VSMCs becoming refractory
to PDGFRb signaling rather than by increased apoptosis. It is
likely that the in vivo configuration of vessel walls provides
stabilizing cues to balance the proliferative potential of mutant
mural cells.
The tunica media is the largest part of the aortic wall and is
composed of concentric musculoelastic layers. Each elastic
lamella consists of a single layer of VSMCs and a layer of extra-
cellular matrix, which is secreted by immature VSMCs during
development and organized into fibers. Four to five intact elastic
lamellae were easily identified in both control and mutant
descending aortas (Figures 2G–2J, brackets). Normally, a single
layer of VSMC nuclei separates each elastic lamella, but the
most striking change in mutant aortas was increased cellularity,
with two to four layers of nuclei between each mutant lamella
(Figures 2G and 2H). VSMC proliferation was significantly
increased in mutant aortas at E18.5, based on BrdU incorpora-Developmental Cell 20,tion (Figures S2A–S2E), but BrdU incorporation
was not increased in cardiomyocytes (data not
shown).
The observed VSMC hyperplasia could be
a response to cardiovascular challenges. Todetermine whether signals transduced by the mutant PDGFRb
can autonomously induce cell proliferation, we placed aortic
rings in collagen gels and cultured them in serum-free media
for 5 days and scored cells that were released from the explant.
Mutant aortas released >4-fold more VSMCs than controls, and
this increase was due to proliferation because it could be
blocked by mitomycin C (Figures S2F and S2G). Because
increased proliferation was seen over several days in vitro, as
well as at E18.5 before any other alteration in aortic size or struc-
ture, we conclude that the mutant PDGFRb autonomously
induces VSMC proliferation.
VSMCs have the ability to alternate between quiescent/
contractile and proliferative/noncontractile states depending
on environmental cues (Owens et al., 2004). We hypothesized
that because PDGFRb signaling significantly increased prolifer-
ation, it might also downregulate genes of the contractile appa-
ratus, which would constitute further evidence of an alternate
phenotypic state. Indeed, wild-type and mutant aorta sections
expressed PDGFRb and mutants contained medial areas nega-
tive for smooth muscle myosin mRNA (Myh11, also called SM-
MHC) (Figures 2K–2N), a definitive marker of mature VSMCs
(Owens et al., 2004). Expression of smooth muscle actin protein
(Acta2, also called aSMA) was also broadly reduced (Figures 2O
and 2P). Gene expression changes in aortic tissue were
measured by qRT-PCR, which showed significantly reduced
Myh11 (mutant level = 0.43 of control), smooth muscle actin
(Acta2), smooth muscle myosin light-chain kinase (Mylk), and
caldesmon, a calcium-binding regulator of smooth muscle
contraction (Cald) (Figure 2Q). Elastin deficiency causes a hyper-
proliferative response in VSMCs (Li et al., 1998), but Eln mRNA
was unchanged in our mutant aortas. Contractile genes were
also expressed at reduced levels in cultured VSMCs, and Eln
was again unchanged (Figure 2Q), indicating a cell-autonomous
phenotype. We conclude that PDGFRb signaling in aortic
VSMCs induces a dedifferentiation phenotype, resulting in thick-
ening of the tunica media and an increase in aortic radius.815–826, June 14, 2011 ª2011 Elsevier Inc. 817
Figure 2. Altered Aortic Wall Architecture and Downregulation of Contractile Genes in Sm22Cre;PDGFRb+/k Smooth Muscle Cells
(A) Staining for b-gal activity (blue) in Sm22Cre;R26RlacZ aorta at E16.5. Activity is seen in aortic smooth muscle (a) as well as mosaic activity in periaortic
mesenchyme (m), esophagus (e), and trachea (t).
(B) Negative control for b-gal activity in Sm22Cre mouse. There is no blue stain.
(C and D) Hematoxylin and eosin staining of ascending aorta in wild-type and Sm22Cre;PDGFRb+/k littermates at P2.
(E and F) Low-magnification images of descending aorta from P30 mice with 2-fold enlargement of the mutant lumen (F). Asterisk marks anterior periaortic
adipose that arises from an Sm22Cre-expressing lineage and is reduced to a rudiment in mutants (see also Figure S5). Images in (E) and (F) are the same
magnification.
(G and H) Higher magnification of aortic wall in (E) and (F), stained with hematoxylin and eosin, with two to four smooth muscle cell nuclei per layer (marked with
brackets) in mutant. Orientation: lumen is up.
(I and J) Aortic wall in (E) and (F), stained with Weigert’s elastic stain to visualize elastic lamellae.
(K–N) In situ hybridization forMyh11 andPDGFRbmRNA (blue stain) in tunicamedia at P20.Myh11 is downregulated inmutant patches without detectablemRNA
(visualized by pink counterstain in L). Same orientation as (G) and (H).
(O and P) Immunofluorescence for Acta2 (green) in tunica media at P20, with reduced protein expression in mutant. Nuclei counterstained with DAPI (blue).
(Q) qRT-PCR on RNA isolated from P20 aorta or cultured VSMCs, showing mutant mRNA levels compared to wild-type (red line), with decreased expression of
contractile genes (Acta2, Myh11, Mylk, Cald1) but not tropoelastin (Eln) (mean ± SD, n = 3 aortas or independent cell lines per genotype). Scale bars, 50 mm.
See also Figure S2.
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PDGFRb Signaling
Increased PDGFRb signaling in pericytes might be expected
to influence angiogenesis and vascular remodeling in tissues818 Developmental Cell 20, 815–826, June 14, 2011 ª2011 Elsevier Ithat are sensitive to normal pericyte function, like the CNS
and the retina. To test this hypothesis, we examined brain and
retinal vasculature in Sox2Cre and Sox2Cre;PDGFRb+/K pups.
Although vessel density was somewhat reduced in P12nc.
Figure 3. Phenotypic Shift in Pericytes from
Sox2Cre;PDGFRb+/K Brains
(A–D) In situ hybridization for Rgs5 (A and B) or
PDGFRb mRNA (C and D) (blue stain) in brain
pericytes at P3.
(E and F) Stain for b-gal activity (blue) expressed
by the XLacZ4 promoter trap in quiescent peri-
cytes of the cerebellum at P12.
(G) Quantification of CNS pericytes expressing
Rgs5, PDGFRb, or XLacZ4 at P3 or P12. Total
pericyte numbers increase over time (Rgs5+ cells).
In mutant CNS, active pericytes (PDGFRb+ cells)
do not regress from P3 to P12, but conversely
there are few quiescent pericytes (XLacZ4+ cells)
(mean ± SD, n = 3 brain stems per genotype and
time point). Scale bars, 50 mm.
See also Figure S3.
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capillary size was increased in mutant brains (Figures S3A–
S3D). Mutant arteries and capillaries in flat-mounted retinas at
P7 were also enlarged (Figures S3E and S3F).
Individual pericytes extend processes to achieve appropriate
coverage of arteries, capillaries, and veins. Insufficient PDGFRb
signaling reduces pericyte coverage of CNS capillaries and
results in poor BBB formation (Armulik et al., 2010; Daneman
et al., 2010). To determine if increased PDGFRb signaling alters
pericyte coverage, we prepared flat-mounted retinas from P7
mice and used double labeling for pericytes (NG2) and endothe-
lial cells (FITS-GS-lectin) (Figure S3E). Pericyte coverage was
increased on all types of mutant vessels, as measured by NG2
area over FITC-GS-lectin (Figures S3E and S3G). We did not
observe CNS or retina aneurisms nor did we observe fibrinogen
or mouse IgG in the brain parenchyma (data not shown), and
therefore, the BBB appears to be intact in mice with increased
PDGFRb signaling, consistent with the high degree of pericyte
coverage. Increased PDGFRb signaling in pericytes increases
vessel coverage in the retina and may also alter vessel diameter
through unknown mechanisms.
Increased PDGFRb signaling might be expected to modulate
pericyte differentiation similar to its observed ability to oppose
aortic VSMC differentiation (Figure 2). A major challenge in
studying pericytes is the lack of definitive markers or indicatorsDevelopmental Cell 20, 815–8of differentiation, but Rgs5 has emerged
as a pericyte-specific marker in the
brain (Bondjers et al., 2003). When com-
paring brains of wild-type and Sox2Cre;
PDGFRb+/K pups at P3 and P12, we
found that the number of Rgs5-express-
ing pericytes was similar between
mutants and controls at P3. However,
at P12 we counted somewhat higher
numbers of Rgs5+ cells in Sox2Cre;
PDGFRb+/K brains (Figures 3A, 3B, and
3G). This is consistent with PDGFRb
as a positive regulator of pericyte pro-
genitor proliferation/migration. In normal
brains, PDGFRb+ pericytes decreased
in number over time, implying pericytedifferentiation with downregulation of the gene. However, in
mutant brains the number of PDGFRb+ pericytes was slightly
higher than controls at P3 and higher still at P12 (Figures 3C,
3D, and 3G), suggesting enrichment of activated or less differen-
tiated pericytes in the population. To label quiescent or mature
pericytes, we took advantage of the XlacZ4 promoter trap, which
marks quiescent pericytes but is dynamically silenced in acti-
vated pericytes (Tidhar et al., 2001). Strikingly, increased
PDGFRb signaling coincided with fewer XlacZ4-expressing peri-
cytes in mutant brains (Figures 3E–3G). In summary, pericytes
accumulate in higher numbers over time in mutant brains, based
on Rgs5 expression. Furthermore, mutants have more pericytes
in an active/progenitor state and fewer in a quiescent/differenti-
ated state compared to controls. Similar changes in the number
of PDGFRb+ and XlacZ4+ cells were seen in other tissues from
Sox2Cre;PDGFRb+/K mice, particularly in skeletal muscle and
both brown and white adipose tissue (data not shown). Taken
together, these results indicate that PDGFRb signaling causes
a shift in the differentiation status of pericytes.
PDGFRb-Activated Pericytes Express Immune
Response Signature Genes
To identify targets of PDGFRb signaling and potentially new
markers for pericyte activation, we used microarray analysis to
compare gene expression in control and mutant pericytes. We26, June 14, 2011 ª2011 Elsevier Inc. 819
Figure 4. Microarray and In Situ Characterization of IRSGs in Sox2Cre;PDGFRb+/K Pericytes
(A) qRT-PCR on RNA isolated from whole P1 brains, showing mutant mRNA levels relative to wild-type (red line), with normal expression of endothelial cell
markers Vegfr2 and Pecam (mean ± SD, n = 3 brains per genotype).
(B) Work flow for isolation of RNA from brain microvessels with attached pericytes.
(C) XLacZ4-positive pericytes (blue) in isolated wild-type microvascular fragments after pull-down with attached Dynabeads (brown); a control experiment
performed in parallel with tissue processed for microarrays.
(D) Differentially expressed pathways in brain microvessels at P1, identified by Ingenuity Pathway Analysis. Canonical pathways are defined by a cluster of related
signature genes, which constitutes the ratio’s denominator. The ratio’s numerator is the number of signature genes that were changed in the microarray data.
p value is the probability that the ratio occurred by chance. IRF, interferon regulator factor; PRR, pattern recognition receptor. Further information is available in
Table S1 and Supplemental Experimental Procedures.
(E–H) ISH for B2m (blue stain) in cerebellum and meninges (m) at P2.
(I–N) ISH for IRSGs Cxcl10, C2, and Ifi27 (blue stain) in mutant pericytes at P12 (I–L) or P7 (M and N).
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was similar between mutants and controls. This time is also
before the appearance of an overt phenotype in the mutant brain
vasculature, and by qRT-PCRwe ensured that major markers for
endothelial cells (Pecam, Vegfr2) were not significantly different
(Figure 4A). We dissociated P1mouse brains and isolatedmicro-
vessel fragments with their associated pericytes by affinity to
anti-PECAM-coated magnetic beads (Figure 4B). This method
has been reported to recover pericytes (Bondjers et al., 2006),
and we confirmed the efficiency of the method in parallel micro-
vessel isolates from XLacZ4 transgenic mice (Figure 4C).
RNA was isolated from four control (wild-type or Sox2Cre) and
four mutant (Sox2Cre;PDGFRb+/K) brains and used to prepare
labeled samples for microarray hybridization. From this analysis,
550 transcripts exhibited >1.5-fold change with a p value <0.05.
Unexpectedly, genes commonly used as pericyte markers were
not scored as significantly changed, including Rgs5 and Cspg4,
suggesting that they may not be targets of PDGFRb signaling.
Instead, most of the changes were in genes not previously asso-
ciated with pericytes. Modeling of these data with two different
pathway-mining software packages revealed significant upregu-
lation of transcripts involved in immune functions (Figure 4D;
Table S1). We selected immune response signaling genes
(IRSGs) from these categories for validation in situ to see if
they were overexpressed in pericytes. We examined expression
of b2-microglobulin (B2m), a highly induced chemokine (Cxcl10),
a representative interferon-regulated gene (Ifi27), and a comple-
ment component (C2). Each of these mRNA transcripts, as well
as protein in the case of b2M, was higher in mutant brain peri-
cytes and meningeal cells (Figures 4E–4N; data not shown).
We tested alternative possibilities that endothelial cells or leuko-
cytes could be the source of overexpressed IRSGs, but results
for these cell types were negative (Figures S4A and S4B).
However, cultured mutant microvascular fragments containing
pericytes continued to overexpress IRSGs (Figure S4C), and
PDGF-BB could induce IRSGs in wild-type microvascular frag-
ments in low-serum conditions (Figure S4C). As additional sup-
porting evidence that IRSG expression is autonomous to peri-
cytes/mesenchymal progenitor cells, we found overexpression
of IRSGs in cultured subcutaneous mesenchymal cells (ScMCs)
even after several passages (see below and Figure S7D). Taken
together, these data show that pericyte plasticity includes the
potential to activate a battery of genes involved in innate and
adaptive immunity, and PDGFRb activity can modulate this
response.
The PDGFRb-induced immune response signature could
modulate inflammatory properties of endothelial cells, leading
to increased leukocyte adhesion and transmigration. Further-
more, many of the IRSGs are chemokines involved in leukocyte
trafficking (Cxcl10, Cxcl9, Cscl11, Cxcl12, Ccl5, and Ccl2; see
Table S1). We used fluorescence-activated cell sorting (FACS)
to examine bone marrow-derived cells in the brain at P2 and
P9. In P2 brains, we found no significant difference between
control and Sox2Cre;PDGFRb+/K brains in the number of
CD45+ cells (all leukocytes) and CD45+Mac1+ double-positive(O) Representative FACS analysis of leukocytes in the brain of control and mutan
populations is seen in Sox2Cre/PDGFRb+/K mutants at P9. Numerical data for ea
See also Figure S4 and Table S1.
Develcells (macrophages, microglia, and some other cells of the innate
immune system). However, at P9 the number of CD45+ and
CD45+Mac1+ cells in the brain was significantly increased in
Sox2Cre;PDGFRb+/K pups (Figure 4O). The potential for peri-
cytes to influence transmigration of leukocytes through vessel
walls has been previously addressed in tumors (Hamzah et al.,
2008). Our findings suggest that pericytes have the potential to
activate a battery of immune response genes that initiate
immune cell recruitment in the brain and possibly other tissues.
Pericyte-mediated inflammatory responses could be an impor-
tant component of autoimmune diseases and may contribute
to the observed lethality in Sox2Cre;PDGFRb+/K pups.
PDGFRb Signaling Blocks White Adipose Differentiation
All PDGFRb+/J and PDGFRb+/K pups generated with epiblast-
specific Cre (Sox2Cre, Meox2Cre) and male germline Cre
(PrmCre) entered growth stasis after the first week (Figure 5A;
data not shown). Mutant pups nursed, and their stomachs con-
tained milk. We could not find any defects in gastrointestinal
vascular or lacteal development that could explain the observed
growth stasis. This phenotype was not seen in smooth muscle-
specific (Sm22Cre) or endothelial and blood cell-specific (Tie2-
Cre) mutants.
Mice are born with brown adipose tissue (BAT), but white
adipose tissue (WAT) only develops postnatally. PDGFRbCre
has been used to lineage trace white adipocytes in development
and to provide evidence that mural cells are white adipocyte
progenitors (Tang et al., 2008). We therefore monitored adipo-
genesis in our mice before growth stasis (P3) and after its onset
(P11–P14). Nascent subcutaneous and inguinal WAT developed
in controls and mutants by P3 (Figures 5B and 5C). At P13,
mutant inguinal and subcutaneous WAT contained reduced
lipids but a higher cell density (Figures 5D–5K). At this time,
only rudimentary mesenteric adipose depots could be detected
inmutants (Figures S5A andS5B). In addition to these changes in
juvenile Sox2 mutants, lineage tracing showed that Sm22Cre is
active inmesenchymal cells (Figure 2A) that give rise to periaortic
adipose (Figure S5C). Closer examination of adult Sm22Cre;
PDGFRb+/K mice revealed isolated reduction of periaortic
adipose (Figures S5D and S5E). Therefore, despite initial differ-
entiation of some adipocytes, WAT failed to fully develop in
mice with increased PDGFRb signaling in pericytes and other
mesenchymal cells. Interscapular BAT was present in newborn
controls and mutants (Figures S5F and S5G), and was not signif-
icantly reduced in P13 pups (data not shown).
To isolate the effect on adipogenesis from additional pheno-
types that may result from PDGFRb activation, we established
cultures of ScMCs from newborn (P1) pups and assayed their
capacity for adipogenesis in vitro. These primary cells spontane-
ously differentiate into adipocytes at low efficiency without
differentiation media (data not shown). Before inducing differen-
tiation, we tested control and Sox2Cre;PDGFRb+/K cells for
expression of PPARg2, a key transcriptional regulator of adipo-
genesis, and Pref-1, a marker for mesenchymal cells and preadi-
pocytes. These genes were modestly increased in mutantts at P2 and P9. Significant increase in gated CD45+Mac1 and CD45+Mac1+
ch gate are the percentage of total cells analyzed. Scale bars, 50 mm.
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Figure 5. Inhibition of White Fat In Vivo
(A) Weight plot of control (combined wild-type, Sox2Cre, and PDGFRb+/(S)K, n = 24) versus Sox2Cre;PDGFRb+/K (n = 10) pups during the second postnatal week
(mean ± SD).
(B and C) Histological sections of flank skin with nascent subcutaneousWAT and inguinal WAT from littermates at P3, stained with oil red O (ORO) to detect lipids
(red).
(D and E) Inguinal WAT at P13 stained with ORO.
(F and G) Inguinal WAT at P13 stained with hematoxylin and eosin.
(H and I) Flank skin and subcutaneous WAT at P13 stained with ORO. WAT is virtually eliminated from mutant skin.
(J and K) Subcutis at P13 stained with hematoxylin and eosin. Scale bars, 50 mm.
See also Figure S5.
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PDGF Signaling and Mesenchyme PlasticityScMCs, but the difference was not significant (Figure 6A).
Control ScMCs treated with differentiation media were highly
adipogenic after 12 days of differentiation, as assessed by oil
red O staining, but Sox2Cre;PDGFRb+/K cells differentiated very
poorly (Figure 6B). We did not see evidence of ScMC differenti-
ation toward brown fat (Figure S6). Control ScMC differentiation
corresponded to induction of adipogenic transcription factors
(PPARg2 and C/EBPa) and differentiation markers (Ap2 and
Adipsin). Consistent with severely reduced lipid accumulation
in mutant ScMCs, C/EBPa, Ap2, and Adipsin were induced at
lower levels in mutant cells (Figure 6C). Taken together, these
results in isolated cells show that increased PDGFRb signaling
in preadipocytes, whichmay be pericytes or other mesenchymal
cells, is inhibitory to white adipocyte differentiation.
Mutant White Adipose Is Composed of Adipocyte
Progenitors and Leukocytes
To uncover developmental mechanisms for the loss of adipose,
we examined P13 WAT for apoptotic cells, vascular regression,
and evidence of preadipocyte accumulation. Few apoptotic cells822 Developmental Cell 20, 815–826, June 14, 2011 ª2011 Elsevier Iwere detected in wild-type or Sox2Cre;PDGFRb+/K adipose by
immunostaining for cleaved caspase-3 (data not shown), sug-
gesting that the loss of adipose is not due to cell death. Reduced
blood supply could oppose adipogenesis because angiogenesis
and adipogenesis are developmentally and functionally linked
(Cao, 2007; Rupnick et al., 2002). However, staining with FITC-
GS-lectin revealed a dense network of capillaries in WAT of
Sox2Cre;PDGFRb+/K pups (Figures 7A and 7B). Finally, we
used expression of PDGFRb and Pref-1 to test for pericyte/
preadipocyte accumulation within mutant WAT. Normal WAT
at P13 contained few PDGFRb-expressing cells and fewer still
Pref-1-expressing preadipocytes, but mutant adipose held
abundant PDGFRb+ and Pref-1+ cells (Figures 7C–7F). Pref-1 is
a marker for preadipocytes that is downregulated during differ-
entiation (Smas and Sul, 1993). Pref-1, also known as Dlk1, is
also a marker reported in embryonic brain pericyte progenitors
(Bondjers et al., 2006). Although forced expression of a soluble
form of Pref-1 can impair adipogenesis in mice (Lee et al.,
2003), we observed normal downregulation of Pref-1 in nascent
WAT at P3 in both controls and mutants (Figures S7A–S7C), andnc.
Figure 6. Inhibition of White Adipocyte Differentiation In Vitro
(A) qRT-PCR on RNA isolated from undifferentiated ScMCs, showing Sox2Cre/PDGFRb+/K mRNA levels compared to controls (red line). Preadipocyte markers
PPARg2 and Pref-1 are slightly increased in mutant cells (mean ± SD, n = 3 independent cultures per genotype).
(B) Oil red O stain performed on control and mutant ScMCs after 12 days of differentiation. Scale bars, 50 mm.
(C) qRT-PCR on RNA isolated from differentiated ScMCs, expressed as fold increase in mRNA levels over basal level in undifferentiated ScMCs. WAT markers
C/EBPa, AP2, and Adipsin are inhibited in mutant cells (mean ± SD, n = 3 independent cultures per genotype).
See also Figure S6.
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PDGF Signaling and Mesenchyme PlasticityPref-1 was only reexpressed in mutant WAT at P13 (Figure 7F).
This is consistent with Pref-1 being a pericyte or preadipocyte
marker rather than being a functional part of our system.
As shown by our in vitro analysis of isolated ScMCs, PDGFRb
plays an intrinsic role in opposing adipocyte differentiation
(Figures 6B and 6C). We also tested the expression of IRSGs
Cxcl10, C2, and Ifi27 in the same cell cultures before inducing
adipogenesis and found IRSGs to be overexpressed in mutant
cells compared to control cells (Figure S7D). The IRSGs were
also overexpressed in nascent WAT of mutant pups at P3
(Figures S7E–S7J). Normal WAT is rich in leukocytes andmacro-
phages. To see if additional immune cells were recruited to
mutant WAT in vivo, we performed FACS of the stromal vascular
fraction of control and mutant inguinal WAT at P9. The total
number of cells in the mutant stromal vascular fraction was
increased 1.5-fold compared to control WAT (data not shown).
The proportion of CD45+Mac1+ double-positive cells was
increased 1.44-fold in mutants (Wt CD45+Mac1+ = 13.30% ±
3.4%; bK CD45+Mac1+ = 19.95% ± 3.05%; n = 3), and the
proportion of CD45+Mac1 leukocytes was 3.59-fold higher
(Wt CD45+Mac1 = 13.83%± 3.4%; bKCD45+Mac1 = 47.8%±
14.25%; n = 3). Therefore, PDGFRb signaling alters the ground
state of adipocyte progenitor cells, which inhibits WAT differen-
tiation. Concomitantly, increased PDGFRb activity induces
IRSGs that lead to recruitment of significant numbers of bone
marrow-derived cells to the hypotrophic WAT. Consistent with
evidence that PDGFRb+ mural cells are adipocyte progenitors
in the newborn mouse (Tang et al., 2008), our findings demon-
strate that PDGFRb activity regulates the balance between
progenitor and differentiated states of mural cells in multiple
tissues.DevelDISCUSSION
We have shown that PDGFRb signaling opposes differentiation
of vascular smooth muscle and pericytes, inhibits the differenti-
ation of white adipocyte progenitors derived from pericytes or
other mesenchymal cells, and maintains progenitor potential
in vivo. Inhibition of adipogenesis was the most striking conse-
quence of retained progenitor potential due to PDGFRb signaling
because WAT became enriched for PDGFRb+ and Pref-1+ cells.
PDGFRb signaling also promoted an immature phenotype in
VSMCs and CNS pericytes. Thus, PDGFRb provides important
regulatory cues to oppose differentiation of mesenchymal
progenitor cells. Engagement of this pathwaymay be highly rele-
vant in the development of MSCs toward therapeutic ends.
Increasing PDGFRb signaling specifically in VSMCs induced
key aspects of a ‘‘phenotypic switch’’ (Owens et al., 2004),
including downregulation of contractile apparatus genes and
increased proliferation, but themice remained healthy into adult-
hood without spontaneous atherosclerosis or neointima forma-
tion. Yet, PDGF expression has been reported in many types
of vascular and inflammatory cells, and PDGFRb signaling
clearly has a role in experimentally induced cardiovascular
disease (Raines, 2004) and cardiac challenge (Chintalgattu
et al., 2010). It is likely that in the context of an intact vessel
wall, properly integrated VSMCs become refractory to PDGF
signaling. Environmental conditions that disrupt matrix contacts
would be expected to synergize with PDGF signaling, resulting in
VSMC activation and cardiovascular disease.
Pericytes converge on newly formed capillaries and produce
extracellular matrix to induce quiescent, leak-resistant, optimally
functional vessels (Carmeliet, 2003; Jain, 2003). Endothelial cellsopmental Cell 20, 815–826, June 14, 2011 ª2011 Elsevier Inc. 823
Figure 7. Progenitor Cells in Mutant WAT
(A and B) Immunofluorescence for capillary endothelium
of inguinal WAT at P13, stained with FITC-GS-lectin.
(C–F) ISH for PDGFRb or Pref-1 (blue stain) in inguinal
adipose at P13. An increase in these markers indicates
the accumulation of pericytes/preadipocytes in mutant
adipose. Scale bars, 50 mm.
See also Figure S7.
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regulate this process (Armulik et al., 2005). When pericytes fail
to adequately coat capillaries in mice with deficient PDGF-B/
PDGFRb signaling, the vascular consequences include leaky
vessels and loss of BBB (Armulik et al., 2010; Daneman et al.,
2010; Hellstro¨m et al., 2001; Lindahl et al., 1997). We show that
increased PDGFRb signaling leads to increased pericyte cover-
age of blood vessels and induced changes in pericyte differ-
entiation. There have been few attempts to define pericyte
‘‘activation’’ in molecular terms (Berger et al., 2005). Our micro-
array profiling and subsequent characterization revealed that a
major outcome of PDGFRb signaling in pericytes and other
mesenchymal progenitors is the activation of a latent immuno-
logical potential. This resulted in recruitment of large numbers
of leukocytes to the brain. Loss of Rgs5 has been shown to alter
pericyte differentiation in tumors and leads to recruitment of
immune cells that improve cancer outcomes (Hamzah et al.,
2008). Our finding that altered pericyte differentiation can lead
to immune cell recruitment in the developing brain suggests
the potential for pericytes to play a role in CNS inflammation or
in autoimmune disease, and this merits further testing. It remains
to be seen whether these aspects of pericyte activation are
helpful or harmful in the adult CNS, and it will be important824 Developmental Cell 20, 815–826, June 14, 2011 ª2011 Elsevier Inc.to understand the previously unappreciated
potential of PDGF to modulate this phenotype.
Many adipocyte progenitors are perivascular
cells, but clearly not all pericytes adopt an adi-
pogenic fate in the organism (Rodeheffer
et al., 2008; Tang et al., 2008; Zeve et al.,
2009). There is also evidence for adipocyte
progenitors that differ from pericytes (Joe
et al., 2010; Majka et al., 2010; Uezumi et al.,
2010). Fat development in vivo is still a poorly
understood process. In our mouse model,
WAT initially appears normal at P3 but is defec-
tive thereafter. This leads us to postulate that
WAT arises from more than one developmental
lineage with PDGFRb having a negative impact
during a second wave of adipogenesis. Our
work clearly shows that PDGFRb signaling
inhibits WAT differentiation in vitro, acting in
adipocyte progenitors that may be pericytes
or anatomically distinct mesenchymal cells.
The antiadipogenic effect of PDGFRb signal-
ing could not have been predicted from previ-
ous developmental studies because PDGFB/
PDGFRb-deficient mice die before the stage
at which most adipogenesis occurs (Leve´en
et al., 1994; Soriano, 1994). Some of the molec-ular steps in fat differentiation, which also support a role for
PDGF in inhibiting adipogenesis, have been described in tissue
culture. In the 3T3-L1 preadipocyte cell line, downregulation of
PDGFRb is one of the first events following treatment with differ-
entiation medium, occurring at just 6 hr (Vaziri and Faller, 1996),
whereas induction of PPARg and C/EBPa is first detectable after
2–3 days, and adipocyte morphology is reached 4–5 days later.
Conversely, addition of PDGF-BB to the differentiation media
partially inhibits lipid accumulation and induction of C/EBPa,
PPARg2, aP2, and adiponectin in 3T3-L1 cells (Artemenko
et al., 2005).
Our findings raise the possibility that agonists or antagonists to
PDGFRs might be useful agents for controlling adipogenesis.
Components of the immune response battery (IRSGs) may also
be candidates for mediating the inhibitory effect on white adipo-
cyte differentiation. However, we have also shown that chronic
activation of PDGFRa can lead to multiorgan fibrosis (Olson
and Soriano, 2009), and PDGF is a potent mitogen that can
promote tumor formation (Andrae et al., 2008; Pietras et al.,
2003). Therefore, focusing on signaling events engaged down-
stream of the PDGFRs may provide more specificity in potential
treatments. Thus, a better understanding of how PDGFRb regu-
lates pericyte or mesenchymal progenitor status and immune
Developmental Cell
PDGF Signaling and Mesenchyme Plasticityresponses could lead to the identification of novel therapeutic
targets for cardiovascular and obesity-related diseases.
EXPERIMENTAL PROCEDURES
Mice
A detailed description of ES cell targeting and vector design is provided in
Supplemental Experimental Procedures. All procedures described in this
study were approved by the Institutional Animal Care and Use Committees
of Mount Sinai and the Oklahoma Medical Research Foundation. Embryos
and pups were examined in mixed C57BL6/129S4 backgrounds, and mutants
generated with Meox2Cre were also examined in a co-isogenic 129S4 back-
ground, with identical phenotypes. All analyses were based on a minimum of
three mutants and littermate controls (wild-type or Cre-only).
Brain Microvessel Purification
Microvessels were purified as described (Bondjers et al., 2006). For each brain,
10 ml rat anti-Pecam antibody (BD PharMingen) was bound to 50 ml anti-rat
Dynabeads (Invitrogen; 110.35) by overnight incubation, followed by washing
with PBS plus 0.1% BSA plus 2 mM EDTA. The next day, P1 pups were sacri-
ficed, and each brain was minced and triturated in 4 ml 13 HBSS (+Ca/Mg)
plus 1% BSA plus 5 mg/ml collagenase type 1 (GIBCO; 17100-017). After
15 min at 37C with gentle rocking, cells and microvascular fragments were
filtered through 100 mmnylonmesh, and rinsed twice with ice-cold wash buffer
(PBS/BSA/EDTA). Cell slurry was then incubated with anti-Pecam Dynabeads
for 30 min at 4C with end-over-end rotation. Beads and attached microves-
sels were recovered with a magnet and washed five times with ice-cold
wash buffer, followed by RNA isolation. Microarray analysis is described in
Supplemental Experimental Procedures.
Flow Cytometry
For FACS analysis, brains and inguinal WAT were excised and single cells iso-
lated by digestion with 0.4% collagenase in DMEM plus 1.5% BSA for 1 hr at
37C. After filtering through a 40 mm filter, cells were resuspended in HBSS
plus 2% FBS, and anti-Fc binding was blocked for 15 min with anti-CD16
(eBioscience) at 4C. Next, cells were labeled with anti-Mac1 (CD11b-PE)
(eBioscience) and anti-CD45.2-FITC (BD PharMingen) for 15 min. Compen-
sation was set using single-labeled samples, samples were sorted on a
FACSCalibur cytometer, and data were analyzed with FlowJo software. For
flow cytometry, single cells were filtered from bone marrow, spleen, and
thymus, and resuspended in HBSS plus 2% FBS. After blocking, cells were
labeled with anti-CD45.2-FITC, and 2 3 106 CD45+ cells were sorted on a
MoFlo cell sorter.
ScMC Isolation and Differentiation
ScMCs were isolated as described (Lichti et al., 2008). Briefly, P0–P1 pups
were sacrificed by CO2 asphyxiation and washed in 70% ethanol. Whole
skins were removed and floated dermis side down on cold 0.25% trypsin
(without EDTA) overnight at 4C. Epidermis was then removed, subcuta-
neous tissue was digested with 0.4 mg/ml collagenase in DMEM plus
1.5% BSA for 1 hr at 37C, and released cells were filtered through
a 100 mm filter. Hair follicle buds were removed by centrifugation at 15 3 g.
ScMCs were then plated at a density of one mouse per 10 cm dish and
grown in DMEM plus 10% FBS supplemented with antibiotics. Twenty-four
to 48 hr later, each culture was expanded onto a 15 cm dish and grown to
confluence. For differentiation assays, passage 2 cells were plated at 5 3
105 cells/6-well dish. Upon reaching confluence, undifferentiated ScMCs
were either harvested for RNA analysis or induced to differentiate. Adipogen-
esis was induced by two cycles of induction/maintenance medium, consist-
ing of 48 hr in induction medium (DMEM plus 10% FBS, 10 mg/ml insulin,
0.25 mg/ml dexamethasone, 0.5 mM IBMX) or 48 hr in maintenance medium
(DMEM plus 10% FBS, 10 mg/ml insulin). After two cycles (8 days), cells were
held for an additional 4 days in maintenance medium. For staining, cells were
fixed in 10% buffered formalin for 10 min, then rinsed in PBS, H2O, and 60%
isopropanol sequentially. Staining was performed with oil red O (0.3% oil red
O in 60% isopropanol) for 30 min, followed by rinse with 60% isopropanol
and H2O, sequentially.DevelACCESSION NUMBERS
Microarray data have been deposited in the Gene Expression Omnibus (GEO)
public database under accession number GSE29284.
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